We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Smart Consumables Manufactured for IVD Markets

By LabMedica International staff writers
Posted on 08 Aug 2011
Smart consumables will be developed and manufactured for the life science and in vitro diagnostic (IVD) markets; the new generation of diagnostic tests will be based on single molecule array (SiMoA) technology.

Production of the Quanterix (Cambridge, MA, USA) SiMoA disc marks the first diagnostic consumable whose assay technology is based on optical disc formats by Sony DADC (Salzburg, Austria). The manufacturing company uses proven high precision and high volume manufacturing processes, which it has pioneered for CD, DVD, and Blu-ray disc.

Quanterix plans to develop and manufacture a fully automated instrument for its SiMoA technology, which will utilize these "smart consumables" to support a menu of diagnostic tests. Quanterix expects to launch the life science instrument and consumables in 2013, followed by an IVD platform to be commercialized in 2014.

"We selected Sony DADC as our consumables partner because they are the clear world leader in the micro structuring and manufacturing of high volume optical products," said Martin Madaus, PhD, Quanterix executive chairman. "Sony DADC's proven optical disc technology provides Quanterix with a consumable that meets the requirements of high sensitivity diagnostic testing both today and into the future. Partnering with Sony DADC on the SiMoA Disc is a major milestone toward our objective of delivering high quality and cost effective solutions to the clinical diagnostics and life science markets."

Related Links:

Quanterix
Sony




New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Thyroid Test
Anti-Thyroid EIA Test
New
Clinical Informatics Platform
CLARION™

Latest Molecular Diagnostics News

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary
08 Aug 2011  |   Molecular Diagnostics

Blood Test Enables Early Detection and Classification of Glioma
08 Aug 2011  |   Molecular Diagnostics

Multi-Biomarker Blood Test Detects Early-Stage Cancers Across Types
08 Aug 2011  |   Molecular Diagnostics